Title: | Sex-specific association of serum cystatin C with the risks of 24 type of cancer: pan-cancer analyses in the UK Biobank |
Journal: | Precision nutrition |
Published: | 7 Jun 2024 |
DOI: | https://doi.org/10.1097/pn9.0000000000000073 |
Title: | Sex-specific association of serum cystatin C with the risks of 24 type of cancer: pan-cancer analyses in the UK Biobank |
Journal: | Precision nutrition |
Published: | 7 Jun 2024 |
DOI: | https://doi.org/10.1097/pn9.0000000000000073 |
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
We aim to investigate the associations of circulating cystatin C (Cyst-C) concentrations with the risk of different cancers in men and women, using a pan-cancer approach, including 24 cancers in UK Biobank. A total of 421,867 cancer-free participants from the UK Biobank study were included. We restricted analyses to cancers with a minimum of 100 recorded cases in men or women. During a median follow-up of 10.7 years, in both men and women, circulating Cyst-C concentrations (per standard deviation [SD] increment) were significantly and positively associated with the risks of kidney cancer, lung cancer, leukemia, mesothelial and soft tissue cancer, multiple myeloma, non-Hodgkin lymphoma and liver cancer, with a range of adjusted hazard ratios (HR) from 1.09 (95% confidence interval [CI]: 1.01-1.18) for kidney cancer in women to 1.27 (95% CI: 1.17-1.38) for liver cancer in women. In addition, only in men, higher Cyst-C concentrations (per SD increment) were associated with higher risks of head and neck cancer (adjusted HR, 1.10; 95% CI: 1.02-1.21), esophagus cancer (adjusted HR, 1.09; 95% CI: 1.01-1.17), and pancreas cancer (adjusted HR, 1.15; 95% CI: 1.07-1.24), as well as a lower risk of prostate cancer (adjusted HR, 0.95; 95% CI: 0.93-0.98). Meanwhile, only in women, higher Cyst-C concentrations (per SD increment) were related to higher risks of brain or central nervous system or intracranial cancer (adjusted HR, 1.18; 95% CI: 1.09-1.27) and urinary tract cancer (adjusted HR, 1.10; 95% CI: 1.02-1.19). Circulating Cyst-C was significantly associated with multiple human cancers in men or women. Our results suggest that circulating Cyst-C may serve as a potential biomarker for identifying multiple human cancers.</p>
Application ID | Title |
---|---|
73201 | Identification of residual risks of non-infectious chronic diseases |
Enabling scientific discoveries that improve human health